sacituzumab govitecan
gilead sciences
['tropics-02', 'breast', 'trodelvy', 'gilead']
the data is in for tropics-02 trial of trodelvy in heavily treated hr+/her2- breast cancer patients, but little agreement on the interpretation of the results #asco22 #oncology 
https://t.co/O0ZJQGMjEP, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate